Lytgobi European Union - English - EMA (European Medicines Agency)

lytgobi

taiho pharma netherlands b.v. - futibatinib - cholangiocarcinoma - antineoplastic agents - lytgobi monotherapy is indicated for the treatment of adult patients with locally advanced or metastatic cholangiocarcinoma with a fibroblast growth factor receptor 2 (fgfr2) fusion or rearrangement that have progressed after at least one prior line of systemic therapy.

TS-ONE Capsule 20 Singapore - English - HSA (Health Sciences Authority)

ts-one capsule 20

taiho pharma asia pacific pte. ltd. - gimeracil; oteracil potassium; tegafur - capsule - 5.8mg - gimeracil 5.8mg; oteracil potassium 19.6mg; tegafur 20mg

TS-ONE Capsule 25 Singapore - English - HSA (Health Sciences Authority)

ts-one capsule 25

taiho pharma asia pacific pte. ltd. - gimeracil; oteracil potassium; tegafur - capsule - 7.25mg - gimeracil 7.25mg; oteracil potassium 24.5mg; tegafur 25mg

S-1TAIHO combination OD tablets T20 (エスワンタイホウ配合OD錠T20) Japan - English - すりの適正使用協議会 RAD-AR Council, Japan

s-1taiho combination od tablets t20 (エスワンタイホウ配合od錠t20)

okayama taiho pharmaceutical co., ltd. - tegafur; gimeracil; oteracil potassium - light blue-green tablet with white central part on one side, diameter: 7.5 mm, thickness: 3.5 mm